Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer

Clinical trial NCT06455072 · UNKNOWN

Trial details

NCT number: NCT06455072
Sponsor: Fujian Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2023-02-01
Primary completion: 2025-01-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.